Construction of a Database for Thrombotic Microangiopathy

What this Trial Is About

Researchers are collecting detailed information on patients with thrombotic microangiopathies (TMA) to build a comprehensive database. This observational study is conducted by the First Affiliated Hospital of Soochow University and aims to gather clinical data, including basic demographics like age and gender, as well as disease-related measurements. The study is planned to include around 200 patients and runs from December 1, 2022, to November 30, 2027. The study involves reviewing patient information through the Hitech case system, telephone follow-ups, and outpatient visits. Data is compiled and managed using Epidata software to construct the database. Participants are patients diagnosed with TMA who meet specific clinical criteria related to blood markers and pathological findings. There is no intervention or treatment being administered; rather, the focus is on data collection and observation. Participants will be followed over time, with researchers monitoring key outcomes such as the occurrence of stroke within five years of entering the database. The study collects clinical data and demographic information through medical records and follow-ups. This monitoring helps researchers understand the progression and complications associated with TMA, with the overall participation lasting up to five years after enrollment.

Construction of a Database for TMA